LifeScienceXchange

LifeScienceXchange offers actionable market insights, technology showcases, thought leadership and essential news, all in a condensed and curated video format. Through these we unite the entire early-stage R&D ecosystem with a shared mission: to accelerate the discovery and development of transformative, life-changing medicines.

Imaging Human-Relevant Models: Leica Microsystems Technology Showcase

Leica Microsystems, a Danaher company, has a broad portfolio covering compound microscopy, digital microscopy, confocal laser scanning, super-resolution microscopy, light-sheet imaging and more. Their microscopy-based imaging systems are helping scientists to unlock the full potential of complex human-relevant models such as organoids. They enable high-resolution visualization of cellular organization, dynamic processes, and disease phenotypes in a 3D context – and across multiple scales. 
eBook: Overcoming Barriers in Organoid Imaging and Analysis
Webinar: Unlocking the Secrets of Organoid Models in Biomedical Research
Webinar: How Efficient is your 3D Organoid Imaging and Analysis Workflow?
eBook: History, Developments and Trends of Microscopy in Cancer Research
App Note: Overcoming Observational Challenges in Organoid 3D Cell Culture
LifeScienceXchange Home Page Banner_MC-0012734

Thought Leadership

Interview with Paul Workman

Interview with Paul Workman

Paul Workman Professor of Pharmacology and Therapeutics, Institute of Cancer Research
Chemical Inducers of Proximity – Non-Degrading Molecular Glue Modalities

Chemical Inducers of Proximity – Non-Degrading Molecular Glue Modalities

Rick Ewing Vice President, Head of Chemistry, Rapafusyn Pharmaceuticals
Zoran Rankovic Director, Centre for Chemical Biology & Therapeutics, St. Jude Children’s Research Hospital
Kyle Eastman VP and Head of Chemistry, Halda Therpeutics
Danette Daniels Vice President of the Protein Degrader Platform, Foghorn Therapeutics
Unlocking the Promise of Protein Degraders: Molecular Glues, PROTACs, and the Path Forward

Unlocking the Promise of Protein Degraders: Molecular Glues, PROTACs, and the Path Forward

Stefan Schiesser Director Of Medicinal Chemistry, AstraZeneca
Advancing Drug Discovery Ebook Ad